CannEpil was always the drug that made sense for MXC - be interesting to see the take up in the UK.
I suspect that it won't be enough to save MXC and I do believe another reason for MXC to single list on the LSE - and ditch the ASX.
Ann: CannEpil now available by Named Patient Request in UK, page-2
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.82M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1612 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 50 | 1 |
View Market Depth
| Last trade - 16.12pm 31/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable